CME vs CPRX · P/E 22, rev $3.59B vs P/E 18, rev $491.7M
CME Group Inc (CME) versus Catalyst Pharmaceuticals Inc (CPRX) — a side-by-side from cached financials, not a winner call.
CME Group Inc (CME) is a financial data & stock exchanges company listed on NASDAQ.
Catalyst Pharmaceuticals Inc (CPRX) is a biotechnology company listed on NASDAQ.
Latest reported CME revenue for 2026-06-30 was $3.59B. Net income was $2.20B. Revenue was up 90.8% from 2026-03-31 to 2026-06-30. CME currently screens at market cap $91.25B and trailing P/E 21.9.
Latest reported CPRX revenue for 2024-12-31 was $491.7M. Net income was $163.9M. Revenue was up 23.5% from 2023-12-31 to 2024-12-31. CPRX currently screens at market cap $3.84B and trailing P/E 18.2.
CME currently screens at market cap $91.25B and trailing P/E 21.9. CPRX currently screens at market cap $3.84B and trailing P/E 18.2.
Not investment advice. Open the CME and CPRX stock pages for the full models.
Not investment advice.